ライフサイエンスコーパス: Geneticin

1 ere positively selected in medium containing geneticin.

2 nce of high concentrations of the antibiotic geneticin.

3 thine (d-Orn), a substrate analog, and G418 (Geneticin), a weak non-competitive inhibitor, was determ

4 By contrast, we found that geneticin, a ribosome-binding antibiotic with translatio

5 ht PTC-containing XP-C cells, treatment with Geneticin and gentamicin resulted in (i) stabilized XPC-

6 We treated the colonies with geneticin and mechanically isolated hFLMPCs, which were

7 s determined after prolonged culture without geneticin and on irradiated cells.

8 of commonly used broad-spectrum antibiotics geneticin and puromycin to kill the non-rescued sex.

9 Chinese hamster ovary cells, selection with Geneticin, and amplification with methotrexate, a cell l

10 ression even after prolonged culture without geneticin, and on irradiated tumor cells.

11 for selection of stable transfectants using Geneticin, and the presence of plasmid in transfectants

12 2-DOS aminoglycosides paromomycin and G418 (geneticin) are compared, using both human and Escherichi

13 om complexes of paromomycin, tobramycin, and Geneticin bound to an A-site oligonucleotide, and paromo

14 After selection in Geneticin, clones of pinin-transfected cells were isolat

15 how chemical modifications of apramycin and geneticin, considered among the least and most toxic ami

16 Treatment with geneticin elicits a multiday response, and residual F9 a

17 e in complexes with several aminoglycosides (geneticin G418, paromomycin, and hygromycin B) and the a

18 aminoglycoside antibiotic read-through agent geneticin (G418) across a diverse range of in vitro repo

19 vidence is now available that gentamicin and Geneticin (G418) can induce the mammalian ribosome to su

20 found that doxycycline, chloramphenicol, and Geneticin (G418) interfered with insertion of selenocyst

21 Geneticin (G418) was then identified as a potent inducer

22 a model of the Leishmania ribosomal A site: Geneticin (G418), a potent aminoglycoside for the treatm

23 he 80S ribosome in complex with paromomycin, geneticin (G418), gentamicin, and TC007, solved at 3.3-

24 odial inhibitors in culture, blasticidin and geneticin (G418), were selected for further study.

25 lls in modified minimal media that contained geneticin (G418).

26 resistance to zeocin, puromycin, hygromycin, geneticin/G418, and blasticidin, respectively.

27 cted discovery that the aminoglycoside G418 (Geneticin) interferes with the ability of stably transfe

28 Application of IQSCMaRTEA reveals that geneticin is much more efficacious in vivo than gentamic

29 Furthermore, geneticin, its metabolites, or better tolerated analogue

30 rt that paromomycin and the related compound geneticin manifest their major in vitro anti-C. parvum a

31 ponsiveness to the readthrough-inducing drug geneticin of 11 rationally selected factor IX (FIX) nons

32 two aminoglycoside antibiotics, neomycin and Geneticin, on the endocytic pathway were studied using a

33 stance gene on the vector was used to create geneticin-resistant stable cell lines.

34 Geneticin selection of BHK-21 cells transfected with Rlu

35 When raised on geneticin-supplemented food, the sex-sorter line establi

36 slation fidelity antibiotics paromomycin and geneticin, to high salt and calcium concentrations, to p